An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units (Q42232248)

19 October 2017

An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units (English)

1 reference

multicenter clinical trial

19 October 2017

0 references

author

Federico Pea

12

1 reference

19 October 2017

8

Stephan Harbarth

1 reference

19 October 2017

Gloria Wong

1

0 references

Mieke Carlier

Mieke Carlier

4

0 references

Fekade Bruck Sime

Fekade Bruck Sime

17

0 references

Jason A. Roberts

Jason A Roberts

21

0 references

Michael S. Roberts

Michael S Roberts

14

0 references

Jeffrey Lipman

Jeffrey Lipman

20

0 references

Jan J De Waele

5

Jan J De Waele

1 reference

19 October 2017

9

Angela Huttner

1 reference

19 October 2017

10

Brett McWhinney

1 reference

19 October 2017

16

Anka Roehr

1 reference

19 October 2017

18

Fabio Silvio Taccone

1 reference

19 October 2017

19

Jacobus P J Ungerer

1 reference

19 October 2017

Alexander Brinkman

2

1 reference

19 October 2017

Russell J Benefield

3

1 reference

19 October 2017

Najoua El Helali

6

1 reference

19 October 2017

Otto Frey

7

1 reference

19 October 2017

Benoit Misset

11

1 reference

19 October 2017

Judit Preisenberger

13

1 reference

19 October 2017

Thomas A Robertson

15

1 reference

19 October 2017

language of work or name

English

0 references

publication date

16 January 2014

1 reference

Journal of Antimicrobial Chemotherapy

19 October 2017

1 reference

19 October 2017

69

1 reference

19 October 2017

1416-1423

1 reference

19 October 2017

5

1 reference

Cost-effectiveness of therapeutic drug monitoring: a systematic review.

19 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Prospective monitoring of cefepime in intensive care unit adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Survival in neutropenic patients with severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Case-control study of drug monitoring of β-lactams in obese critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Augmented renal clearance: implications for antibacterial dosing in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Antibiotic resistance: location, location, location

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Pharmacokinetics of meropenem in critically ill patients with severe infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Daily serum piperacillin monitoring is advisable in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Population pharmacokinetics of ceftazidime in burn patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

The phenomenon of the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Pharmacodynamics of cefepime in patients with Gram-negative infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Reversible bone marrow depression by high-dose piperacillin/tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

Therapeutic drug monitoring of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT523

21 January 2018

Identifiers

DOI

10.1093/JAC/DKT523

1 reference

19 October 2017

1 reference